Population Pharmacokinetics and Safety of Dasatinib in Chinese Children with Core-Binding Factor Acute Myeloid Leukemia

被引：0
|
作者：
Fan Yang
Li Zhang
Bei-Bei Zhao
Jing-Liao Zhang
Xi-Ting Liu
Xue Li
Bo-Hao Tang
Yue Zhou
Xin-Mei Yang
John van den Anker
Xiao-Fan Zhu
Wei Zhao
机构：
[1] Shandong University,Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Pediatrics, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital
[3] The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital,Department of Clinical Pharmacy, Clinical Trial Center
[4] Shandong Engineering and Technology Research Center for Pediatric Drug Development,Division of Clinical Pharmacology
[5] Shandong Medicine and Health Key Laboratory of Clinical Pharmacy,Departments of Pediatrics, Pharmacology and Physiology, Genomics and Precision Medicine, School of Medicine and Health Sciences
[6] Children’s National Hospital,Department of Paediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel
[7] George Washington University,Department of Clinical Pharmacy, School of Pharmaceutical Sciences
[8] University of Basel,undefined
[9] Shandong University,undefined
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：71 / 81
页数：10
相关论文
共 50 条
  • [21] Molecular Characterization of Relapsed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Agrawal, Mridul
    Corbacioglu, Andrea
    Jahn, Nikolaus
    Bullinger, Lars
    Teleanu, Maria-Veronica
    Gaidzik, Verena I.
    Weber, Daniela
    Goehring, Gudrun
    Luebbert, Michael
    Fiedler, Walter
    Brossart, Peter
    Kindler, Thomas
    Radsak, Markus
    Ringhoffer, Mark
    Goetze, Katharina S.
    Greil, Richard
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Schlenk, Richard F.
    Doehner, Hartmut
    Paschka, Peter
    Doehner, Konstanze
    BLOOD, 2015, 126 (23)
  • [22] Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?
    Paschka, Peter
    Doehner, Konstanze
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 209 - 219
  • [23] The genomic landscape of core-binding factor acute myeloid leukemias
    Zachary J Faber
    Xiang Chen
    Amanda Larson Gedman
    Kristy Boggs
    Jinjun Cheng
    Jing Ma
    Ina Radtke
    Jyh-Rong Chao
    Michael P Walsh
    Guangchun Song
    Anna K Andersson
    Jinjun Dang
    Li Dong
    Yu Liu
    Robert Huether
    Zhongling Cai
    Heather Mulder
    Gang Wu
    Michael Edmonson
    Michael Rusch
    Chunxu Qu
    Yongjin Li
    Bhavin Vadodaria
    Jianmin Wang
    Erin Hedlund
    Xueyuan Cao
    Donald Yergeau
    Joy Nakitandwe
    Stanley B Pounds
    Sheila Shurtleff
    Robert S Fulton
    Lucinda L Fulton
    John Easton
    Evan Parganas
    Ching-Hon Pui
    Jeffrey E Rubnitz
    Li Ding
    Elaine R Mardis
    Richard K Wilson
    Tanja A Gruber
    Charles G Mullighan
    Richard F Schlenk
    Peter Paschka
    Konstanze Döhner
    Hartmut Döhner
    Lars Bullinger
    Jinghui Zhang
    Jeffery M Klco
    James R Downing
    Nature Genetics, 2016, 48 : 1551 - 1556
  • [24] The genomic landscape of core-binding factor acute myeloid leukemias
    Faber, Zachary J.
    Chen, Xiang
    Gedman, Amanda Larson
    Boggs, Kristy
    Cheng, Jinjun
    Ma, Jing
    Radtke, Ina
    Chao, Jyh-Rong
    Walsh, Michael P.
    Song, Guangchun
    Andersson, Anna K.
    Dang, Jinjun
    Dong, Li
    Liu, Yu
    Huether, Robert
    Call, Zhongling
    Mulder, Heather
    Wu, Gang
    Edmonson, Michael
    Rusch, Michael
    Qu, Chunxu
    Li, Yongjin
    Vadodaria, Bhavin
    Wang, Jianmin
    Hedlund, Erin
    Cao, Xueyuan
    Yergeau, Donald
    Nakitandwe, Joy
    Pounds, Stanley B.
    Shurtleff, Sheila
    Fulton, Robert S.
    Fulton, Lucinda L.
    Easton, John
    Parganas, Evan
    Pui, Ching-Hon
    Rubnitz, Jeffrey E.
    Dingo, Li
    Mardis, Elaine R.
    Wilson, Richard K.
    Gruber, Tanja A.
    Mullighan, Charles G.
    Schlenk, Richard F.
    Paschka, Peter
    Doehner, Konstanze
    Doehner, Hartmut
    Bullinger, Lars
    Zhang, Jinghui
    Klco, Jeffery M.
    Downing, James R.
    NATURE GENETICS, 2016, 48 (12) : 1551 - 1556
  • [25] Survival Is Poorer in Patients With Secondary Core-binding Factor Acute Myelogenous Leukemia Compared With De Novo Core-binding Factor Leukemia
    Borthakur, Gautam
    Lin, E.
    Jain, Nitin
    Estey, Elihu E.
    Cortes, Jorge E.
    O'Brien, Susan
    Faderl, Stefan
    Ravandi, Farhad
    Pierce, Sherry
    Kantarjian, Hagop
    CANCER, 2009, 115 (14) : 3217 - 3221
  • [26] Prognostic Markers in Core-Binding Factor Acute Myeloid Leukaemia
    Prabahran, Ashvind A.
    Tacey, Mark
    Fleming, Shaun
    Strong, Danielle
    Wei, Andrew
    Tate, Courtney
    Marlton, Paula
    Wight, Joel
    Grigg, Andrew
    Tuckfield, Annabel
    Szer, Jeff
    Ritchie, David S.
    Chee, Lynette C. Y.
    BLOOD, 2015, 126 (23)
  • [27] Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia
    Itzykson, Raphael
    Duployez, Nicolas
    Fasan, Annette
    Decool, Gauthier
    Marceau-Renaut, Alice
    Meggendorfer, Manja
    Jourdan, Eric
    Petit, Arnaud
    Lapillonne, Helene
    Micol, Jean-Baptiste
    Cornillet-Lefebvre, Pascale
    Ifrah, Norbert
    Leverger, Guy
    Dombret, Herve
    Boissel, Nicolas
    Haferlach, Torsten
    Preudhomme, Claude
    BLOOD, 2018, 132 (02) : 187 - 196
  • [28] Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
    B F Goemans
    Ch M Zwaan
    M Miller
    M Zimmermann
    A Harlow
    S Meshinchi
    A H Loonen
    K Hählen
    D Reinhardt
    U Creutzig
    G J L Kaspers
    M C Heinrich
    Leukemia, 2005, 19 : 1536 - 1542
  • [29] Mutational Landscape of Relapsed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Dolnik, Anna
    Jahn, Nikolaus
    Strang, Eric
    Cocciardi, Sibylle
    Rucker, Frank G.
    Panina, Ekaterina
    Blatte, Tamara J.
    Herzig, Julia Katharina
    Corbacioglu, Andrea
    Weber, Daniela
    Schrade, Anika
    Gaidzik, Verena I.
    Skambraks, Sabrina
    Gotze, Katharina S.
    Luebbert, Michael
    Fiedler, Walter
    Schroeder, Thomas
    Hahn, Corinna
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Paschka, Peter
    Dohner, Hartmut
    Dohner, Konstanze
    Bullinger, Lars
    BLOOD, 2020, 136
  • [30] Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
    Goemans, BF
    Zwaan, CM
    Miller, M
    Zimmermann, M
    Harlow, A
    Meshinchi, S
    Loonen, AH
    Hählen, K
    Reinhardt, D
    Creutzig, U
    Kaspers, GJL
    Heinrich, MC
    LEUKEMIA, 2005, 19 (09) : 1536 - 1542
12345